Certuity’s NovoCure NVCR Stock Holding History

Certuity’s Portfolio NVCR Stock Details NVCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$143K	Buy	13,124 +2,102	+19%	+$26.3K	0.01%	617
2025 Q4	$143K	Buy	+11,022	New	+$141K	0.01%	568

Other funds holding NVCR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

QCM

Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return

Certuity's NVCR Position: Q1 2026 in Review

Certuity increased its NovoCure (NVCR) stake by 19% in Q1 2026, buying an estimated $26.3K and bringing the position to 13,124 shares worth $143K. The position accounts for 0.01% of the portfolio, ranked #617.

Certuity first reported a position in NVCR in Q4 2025 and has held it in 2 quarters since. 222 funds tracked by Wall St. Rank hold NVCR as of Q1 2026.

Certuity held 13,124 shares of NovoCure worth $143K as of Q1 2026.
Certuity bought 2,102 NovoCure shares in Q1 2026, an estimated $26.3K.
NovoCure made up 0.01% of Certuity's portfolio in Q1 2026, its #617 holding.
Certuity first reported a position in NovoCure in Q4 2025 and has held it in 2 quarters since.
222 funds tracked by Wall St. Rank held NovoCure as of Q1 2026.

Based on Certuity's 13F filing for Q1 2026, filed 11 May 2026.